CompoAtlas

Juice PLUS®+KOŠĻĀJAMĀS TABLETES OGU MAISĪJUMS (2020.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000198/2020
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
The Juice Plus + Company GmbH
Manufacturer
F. Hunziker + Co AG
Origin
Vācija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
4 tabletes
Published pack size
košļājamās tabletes pa 2,5 g
Published packaging
120 tabletes

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
C VITAMĪNSvitamins ; C VITAMĪNS ; 29 ; mgVitamine CVitamin or mineral
E VITAMĪNSvitamins ; E VITAMĪNS ; 5 ; mg α-TEVitamine EVitamin or mineral
Augstās krūmmellenes augļu pulverisplants ; Augstās krūmmellenes augļu pulveris ; Vaccinium corymbosum ; 44 ; mgvaccinium corymbosumPlant
Vīnogas augļu pulverisplants ; Vīnogas augļu pulveris ; Vitis labrusca ; 106 ; mgvitis labruscaPlant
Granātābola augļu pulverisplants ; Granātābola augļu pulveris ; Punica granatum ; 56 ; mgpunica granatumPlant
Lielogu dzērvenes ogu pulverisplants ; Lielogu dzērvenes ogu pulveris ; Vaccinium macrocarpon ; 28 ; mgvaccinium macrocarponPlant
Kazenes ogu pulverisplants ; Kazenes ogu pulveris ; Rubus fruticosus ; 22 ; mgrubus fruticosusPlant
Melleņu ogu pulverisplants ; Melleņu ogu pulveris ; Vaccinium myrtillus ; 12 ; mgvaccinium myrtillusPlant
Meža avenes ogu pulverisplants ; Meža avenes ogu pulveris ; Rubus idaeus ; 10 ; mgrubus idaeusPlant
Melnā plūškoka augļu pulverisplants ; Melnā plūškoka augļu pulveris ; Sambucus nigra ; 6 ; mgsambucus nigraPlant
Upenes ogu pulverisplants ; Upenes ogu pulveris ; Ribes nigrum ; 6 ; mgribes nigrumPlant
Kakao sēklu pulverisplants ; Kakao sēklu pulveris ; Theobroma cacao ; 176 ; mgtheobroma cacaoPlant
Zaļās tējas lapu ekstrakts (6:1)plants ; Zaļās tējas lapu ekstrakts (6:1) ; Camellia sinensis ; 36 ; mgcamellia sinensisPlant
Apelsīna augļu ekstraktsplants ; Apelsīna augļu ekstrakts ; Citrus sinensis ; 6 ; mgcitrus sinensisPlant
Vīnogu sēklu ekstrakts (10-15:1)plants ; Vīnogu sēklu ekstrakts (10-15:1) ; Vitis vinifera ; 6 ; mgvitis viniferaPlant
Ingvera sakneņa pulverisplants ; Ingvera sakneņa pulveris ; Zingiber officinale ; 26 ; mgzingiber officinalePlant
Artišoka lapu ekstraktsplants ; Artišoka lapu ekstrakts ; Cynara scolymus ; 8 ; mgcynara scolymusPlant
Tapiokas sīrupsotherIngredients ; Tapiokas sīrupsNot recognisedRole not identified
Rezistentais maltodekstrīnsotherIngredients ; Rezistentais maltodekstrīnsNot recognisedRole not identified
Cukurniedru cukursotherIngredients ; Cukurniedru cukursNot recognisedRole not identified
Pektīns (E440)otherIngredients ; Pektīns (E440)Listed as food additive E 440 (EU Union list)Role not identified
Vīnskābe (E334)otherIngredients ; Vīnskābe (E334)Listed as food additive E 334 (EU Union list)Role not identified
Pienskābe (E270)otherIngredients ; Pienskābe (E270)Listed as food additive E 270 (EU Union list)Role not identified
AromatizētājiotherIngredients ; AromatizētājiNot recognisedRole not identified
Kokosriekstu eļļaotherIngredients ; Kokosriekstu eļļaNot recognisedRole not identified
Karnaubvasks (E903)otherIngredients ; Karnaubvasks (E903)Listed as food additive E 903 (EU Union list)Role not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Šveice

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Augstās krūmmellenes augļu pulveris
    Read the warning, when it applies and the studies cited

    Blueberry

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).

    Sources cited by Health Canada (4)
    • ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
    • Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Randomised trial
    • Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
    • IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.

    Health Canada monograph dated 29 August 2025

  • Granātābola augļu pulveris
    Read the warning, when it applies and the studies cited
  • Lielogu dzērvenes ogu pulveris
    Read the warning, when it applies and the studies cited

    CRANBERRY - VACCINIUM MACROCARPON

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Sources cited by Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Sources cited by Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    DRIED CRANBERRY JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    Sources cited by Health Canada (2)
    • Gettman MT, Ogan K, Brinkley LJ, Adams-Huet B, Pak CYC, Pearle MS. Effect of cranberry juice consumption on urinary stone risk factors. The Journal of Urology 2005;174(2):590-594. PubMed Randomised trial
    • Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57(1):26-29. PubMed

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    Sources cited by Health Canada (4)
    • Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006;26(9):1314-1319. PubMed
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Grant P. Warfarin and cranberry juice: an interaction? The Journal of Heart Valve Disease 2004;13(1):25-26. PubMed Case report
    • Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. American Journal of Therapeutics 2005;13(3):283-284.

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

  • Melleņu ogu pulveris
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Melnā plūškoka augļu pulveris
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    Sources cited by Health Canada (1)
    • Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    Sources cited by Health Canada (2)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
    • Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Ingvera sakneņa pulveris
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Juice PLUS®+KOŠĻĀJAMĀS TABLETES OGU MAISĪJUMS (2020.)”, https://compoatlas.com/en/supplements/latvia/8688-juice-plus-koslajamas-tabletes-ogu-maisijums-2020, updated 28 October 2026.

Enter to analyse, Shift+Enter for a new line